KRAS and neoplasm: Tran et al. identified a polyclonal CD8+ T cell from a patient with metastatic colorectal cancer which responded to KRAS G12D mutation tumor cells; objective regression was observed after adoptive transfer TILs specifically targeted KRAS G12D (67).